Category: News

Professor Per Damkier (Department of Clinical Pharmacology, Odense University Hospital, Denmark) has produced a critical evaluation of the recent navigation guide review of evidence on acetaminophen (paracetamol) use in pregnancy and neurodevelopmental disorders in the offspring (see the navigation guide review here).

A new study of neurodevelopmental delay risks following paternal valproate use has been published. More information is available here. Photo by nappy, downloaded from Pexels.

Researchers from Liverpool University have published an umbrella review of systematic reviews investigating maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder. The authors concluded that confidence in the current evidence was considered low to critically low. More information is available here. Photo by James Yarema on Unsplash

A nationwide, register-based, case-control study, using linked Norwegian population-level administrative data has identified associations between ADHD medication use in early pregnancy and miscarriage. More information is available here. Photo by Lance Reis on Unsplash

Researchers have analysed data from the Teva Pharmaceutical Industries modafinil/armodafinil pregnancy exposure registry, to provide a final analysis of dataset. The registry describes a high incidence of major congenital malformation (13.1%). More details available here.

ENTIS members Prof Per Damkier and Dr Erika Gram have published a commentary discussing the methodological advantages and limitations of a new study of Commentary published discussing a recent study of acetaminophen exposure and childhood attention deficit hyperactivity disorder (Baker et al. 2025 – see here). Photo by Tara Winstead downloaded from Pexels

Researchers affiliated with the Hamamatsu University School of Medicine in Japan have published a systematic review and meta-analysis of observational studies which investigated the association between prenatal ZIKV exposure and neurodevelopmental outcomes in offspring without congenital anomalies at birth. More information can be found here.